Structure and Inhibition Mechanism of the Human Citrate Transporter NaCT

Overview

Journal Nature

Specialty Science

Date 2021 Feb 18

PMID 33597751

Citations 36

Authors

David B Sauer

Jinmei Song

Bing Wang

Jacob K Hilton

Nathan K Karpowich

Joseph A Mindell

William J Rice

Da-Neng Wang

Affiliations

Soon will be listed here.

Abstract

Citrate is best known as an intermediate in the tricarboxylic acid cycle of the cell. In addition to this essential role in energy metabolism, the tricarboxylate anion also acts as both a precursor and a regulator of fatty acid synthesis. Thus, the rate of fatty acid synthesis correlates directly with the cytosolic concentration of citrate. Liver cells import citrate through the sodium-dependent citrate transporter NaCT (encoded by SLC13A5) and, as a consequence, this protein is a potential target for anti-obesity drugs. Here, to understand the structural basis of its inhibition mechanism, we determined cryo-electron microscopy structures of human NaCT in complexes with citrate or a small-molecule inhibitor. These structures reveal how the inhibitor-which binds to the same site as citrate-arrests the transport cycle of NaCT. The NaCT-inhibitor structure also explains why the compound selectively inhibits NaCT over two homologous human dicarboxylate transporters, and suggests ways to further improve the affinity and selectivity. Finally, the NaCT structures provide a framework for understanding how various mutations abolish the transport activity of NaCT in the brain and thereby cause epilepsy associated with mutations in SLC13A5 in newborns (which is known as SLC13A5-epilepsy).

Citing Articles

Biallelic loss-of-function variants result in impaired sulfate transport and skeletal phenotypes, including short stature, scoliosis, and skeletal dysplasia.

Tise C, Ashton K, de Hayr L, Lee K, Patkar O, Krzesinski E Genet Med Open. 2025; 3:101958.

PMID: 39925707 PMC: 11803892. DOI: 10.1016/j.gimo.2024.101958.

Cryo-EM structures reveal the H/citrate symport mechanism of INDY.

Kim S, Park J, Choi S, Kim J, Jin M Life Sci Alliance. 2025; 8(4).

PMID: 39884835 PMC: 11782487. DOI: 10.26508/lsa.202402992.

Substrate translocation and inhibition in human dicarboxylate transporter NaDC3.

Li Y, Song J, Mikusevic V, Marden J, Becerril A, Kuang H Nat Struct Mol Biol. 2024; .

PMID: 39622972 DOI: 10.1038/s41594-024-01433-0.

Structural basis for the reaction cycle and transport mechanism of human Na-sulfate cotransporter NaS1 (SLC13A1).

Chen X, Zhang Y, Yin J, Liu C, Xie M, Wang Y Sci Adv. 2024; 10(47):eado6778.

PMID: 39576865 PMC: 11584011. DOI: 10.1126/sciadv.ado6778.

Structure and selectivity of a glutamate-specific TAXI TRAP binding protein from Vibrio cholerae.

Davies J, Daab A, Massouh N, Kirkland C, Strongitharm B, Leech A J Gen Physiol. 2024; 156(12).

PMID: 39556531 PMC: 11574862. DOI: 10.1085/jgp.202413584.

References

Spencer A, Lowenstein J . The supply of precursors for the synthesis of fatty acids. J Biol Chem. 1962; 237:3640-8. View

Fang M, Lowenstein J . Citrate and the conversion of carbohydrate into fat. The regulation of fatty acid synthesis by rat liver extracts. Biochem J. 1967; 105(2):803-11. PMC: 1198381. DOI: 10.1042/bj1050803. View

Shrago E, Spennetta T, Gordon E . Fatty acid synthesis in human adipose tissue. J Biol Chem. 1969; 244(10):2761-6. View

Thevenon J, Milh M, Feillet F, St-Onge J, Duffourd Y, Juge C . Mutations in SLC13A5 cause autosomal-recessive epileptic encephalopathy with seizure onset in the first days of life. Am J Hum Genet. 2014; 95(1):113-20. PMC: 4085634. DOI: 10.1016/j.ajhg.2014.06.006. View

Hardies K, de Kovel C, Weckhuysen S, Asselbergh B, Geuens T, Deconinck T . Recessive mutations in SLC13A5 result in a loss of citrate transport and cause neonatal epilepsy, developmental delay and teeth hypoplasia. Brain. 2015; 138(Pt 11):3238-50. DOI: 10.1093/brain/awv263. View

Wellen K, Hatzivassiliou G, Sachdeva U, Bui T, Cross J, Thompson C . ATP-citrate lyase links cellular metabolism to histone acetylation. Science. 2009; 324(5930):1076-80. PMC: 2746744. DOI: 10.1126/science.1164097. View

Inoue K, Zhuang L, Maddox D, Smith S, Ganapathy V . Structure, function, and expression pattern of a novel sodium-coupled citrate transporter (NaCT) cloned from mammalian brain. J Biol Chem. 2002; 277(42):39469-76. DOI: 10.1074/jbc.M207072200. View

Inoue K, Fei Y, Zhuang L, Gopal E, Miyauchi S, Ganapathy V . Functional features and genomic organization of mouse NaCT, a sodium-coupled transporter for tricarboxylic acid cycle intermediates. Biochem J. 2003; 378(Pt 3):949-57. PMC: 1224018. DOI: 10.1042/BJ20031261. View

Gopal E, Miyauchi S, Martin P, Ananth S, Srinivas S, Smith S . Expression and functional features of NaCT, a sodium-coupled citrate transporter, in human and rat livers and cell lines. Am J Physiol Gastrointest Liver Physiol. 2006; 292(1):G402-8. DOI: 10.1152/ajpgi.00371.2006. View

10.

Li L, Li H, Garzel B, Yang H, Sueyoshi T, Li Q . SLC13A5 is a novel transcriptional target of the pregnane X receptor and sensitizes drug-induced steatosis in human liver. Mol Pharmacol. 2015; 87(4):674-82. PMC: 4366797. DOI: 10.1124/mol.114.097287. View

11.

Brachs S, Winkel A, Tang H, Birkenfeld A, Brunner B, Jahn-Hofmann K . Inhibition of citrate cotransporter Slc13a5/mINDY by RNAi improves hepatic insulin sensitivity and prevents diet-induced non-alcoholic fatty liver disease in mice. Mol Metab. 2016; 5(11):1072-1082. PMC: 5081411. DOI: 10.1016/j.molmet.2016.08.004. View

12.

Birkenfeld A, Lee H, Guebre-Egziabher F, Alves T, Jurczak M, Jornayvaz F . Deletion of the mammalian INDY homolog mimics aspects of dietary restriction and protects against adiposity and insulin resistance in mice. Cell Metab. 2011; 14(2):184-95. PMC: 3163140. DOI: 10.1016/j.cmet.2011.06.009. View

13.

Rogina B, Reenan R, Nilsen S, Helfand S . Extended life-span conferred by cotransporter gene mutations in Drosophila. Science. 2000; 290(5499):2137-40. DOI: 10.1126/science.290.5499.2137. View

14.

Wang P, Neretti N, Whitaker R, Hosier S, Chang C, Lu D . Long-lived Indy and calorie restriction interact to extend life span. Proc Natl Acad Sci U S A. 2009; 106(23):9262-7. PMC: 2685744. DOI: 10.1073/pnas.0904115106. View

15.

Fei Y, Liu J, Inoue K, Zhuang L, Miyake K, Miyauchi S . Relevance of NAC-2, an Na+-coupled citrate transporter, to life span, body size and fat content in Caenorhabditis elegans. Biochem J. 2003; 379(Pt 1):191-8. PMC: 1224044. DOI: 10.1042/BJ20031807. View

16.

Bergeron M, Clemencon B, Hediger M, Markovich D . SLC13 family of Na⁺-coupled di- and tri-carboxylate/sulfate transporters. Mol Aspects Med. 2013; 34(2-3):299-312. DOI: 10.1016/j.mam.2012.12.001. View

17.

Pajor A . Sodium-coupled dicarboxylate and citrate transporters from the SLC13 family. Pflugers Arch. 2013; 466(1):119-30. DOI: 10.1007/s00424-013-1369-y. View

18.

Joshi A, Pajor A . Role of conserved prolines in the structure and function of the Na+/dicarboxylate cotransporter 1, NaDC1. Biochemistry. 2006; 45(13):4231-9. PMC: 2547120. DOI: 10.1021/bi052064y. View

19.

Willmes D, Kurzbach A, Henke C, Schumann T, Zahn G, Heifetz A . The longevity gene INDY (I'm Not Dead Yet) in metabolic control: Potential as pharmacological target. Pharmacol Ther. 2017; 185:1-11. DOI: 10.1016/j.pharmthera.2017.10.003. View

20.

Huard K, Brown J, Jones J, Cabral S, Futatsugi K, Gorgoglione M . Discovery and characterization of novel inhibitors of the sodium-coupled citrate transporter (NaCT or SLC13A5). Sci Rep. 2015; 5:17391. PMC: 4664966. DOI: 10.1038/srep17391. View